Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems
Launched by KAROLINSKA INSTITUTET · Oct 20, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called internet-based cognitive behavioral therapy (iCBT) that has been specially adapted for Arabic-speaking refugee and migrant youth. The goal is to see if this online therapy can help reduce common mental health issues such as depression, anxiety, and stress, which many young people in this community face. The researchers believe that those who participate in the iCBT program will feel better compared to those who do not receive this treatment.
To join the study, participants need to be between the ages of 15 and 29, have a refugee or migrant background, and must be able to read and write in Arabic. They should also have a stable internet connection and access to a device like a computer or smartphone. The program lasts for 6 to 10 weeks, and participants should be able to commit to it during that time. However, individuals with severe mental health issues, substance abuse problems, or those currently receiving other psychological treatments will not be eligible for this trial. Overall, this study aims to provide important support to young people facing mental health challenges in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 15 and 29.
- • A score above the cut-off 1.75 on HSCL-25
- • Has a refugee or migrant background
- • Has a good and stable internet connection
- • Has access to a computer, a tablet or a smartphone
- • Is fluent in reading and writing Arabic
- • Has the ability to dedicate time to take part in the intervention for 6-10 weeks.
- Exclusion Criteria:
- • Is suffering from a severe mental illness, such as psychosis or severe depression.
- • Is suffering from substance abuse
- • Is undergoing a psychological treatment
- • Has a high risk of suicide
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
Patients applied
Trial Officials
Gerhard Andersson, PhD
Principal Investigator
Linkoeping University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported